Risk of ischemic stroke, hemorrhagic stroke, bleeding, and death in patients switching from warfarin to dabigatran after an ablation
27 August 2016 (00:00 - 00:00)
Organised by:
About the speaker

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
4 More presentations in this session
Professor D. Scherr (Graz, AT)
Professor Y. De Greef (Antwerp, BE)
Access the full session
The Event
ESC Congress 2016
27 August - 31 August 2016
